Effectiveness of a Wearable Device-based Assisted Post-stroke Rehabilitation System
The Cost-effectiveness Analysis of a Wearable Device-based Assisted Rehabilitation System for Discharged Patient With Stroke
1 other identifier
interventional
140
0 countries
N/A
Brief Summary
Multidisciplinary rehabilitation facilitates functional recovery after stroke, and adherence to rehabilitation guidelines is associated with improved outcomes. We assessed the efficacy of a wearable device-assisted rehabilitation system in addition to conventional therapy compared to conventional therapy alone. A total of 127 eligible acute stroke inpatients were enrolled. There were 76 males (59.8%). The mean age of the participants was 57.45 years; 63 and 64 participants were randomized to the WG and CG, respectively. Both groups showed significant improvements in mRS scores at 90 days (WG: -0.68 \[95% confidence interval (CI), -0.94 to -0.42\]; CG: -0.56 \[95% CI, -0.74 to -0.38\]; P\<0.0001), but only the WG had significant improvements between 30 and 90 days (-0.36; 95% CI, -0.72, -0.007; P=0.049). Both groups had significant improvements in secondary outcomes at 90 days, but there was no difference between groups.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Nov 2015
Typical duration for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2018
CompletedFirst Submitted
Initial submission to the registry
July 31, 2021
CompletedFirst Posted
Study publicly available on registry
August 9, 2021
CompletedMay 17, 2022
May 1, 2022
2 years
July 31, 2021
May 15, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The primary outcome measure was changed in mRS, which was defined by scores of 0 to 4 on the modified Rankin scale
The primary outcome measure was changed in mRS, which was defined by scores of 0 to 4 on the modified Rankin scale, a global seven-level measure of functioning in which scores of 0 or 1 indicate a good outcome with no or minimal neurologic symptoms, scores of 2 to 5 indicate a poor outcome with increasing degree of disability, and 6 indicates death.
Baseline, 30 days and 90 days
Secondary Outcomes (4)
Change in Barthel Index (BI) at 30 days, 90 days
Baseline, 30 days and 90 days
Change in upper limb (UL) function (Stream Wolf Motor Function Test)
Baseline, 30 days and 90 days
Change in functional status (Functional Independence Measure)
Baseline, 30 days and 90 days
Change in static and dynamic balance ability (Berg balance scale)
Baseline, 30 days and 90 days
Study Arms (2)
Study Arm
ACTIVE COMPARATORMobile device-assisted rehabilitation
Control Arm
ACTIVE COMPARATORIn-person therapist-supervised rehabilitation
Interventions
A Wearable Device-Based Assisted Post-Stroke Rehabilitation system
In-person therapist-supervised rehabilitation
Eligibility Criteria
You may qualify if:
- Able to provide signed informed consent prior to study entry and understand the nature of this study and agree to adhere to all study protocol requirements.
- Males and females 20-75 years of age at the time of signing the informed consent
- Patients with first-ever acute ischemic or hemorrhagic stroke diagnosed by a neurologist or neurosurgeon within 4-12 weeks of onset,
- A baseline modified Rankin Scale score 2-4 on enrollment,
- A designated caregiver for each patient willing to assist the patient to be engaged in WEAR using the mobile embedded with APP.
You may not qualify if:
- Planning to have further rehabilitation in other hospital and could be followed up in the participating hospital.
- The caregiver of patients not willing to assist patients to be engaged in WEAR.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (1)
Ho HJ, Wu LC, Wu EH, Lee SF, Lee TH, Chiang SH, Chen CH, Chen HY, Pan SJ, Chen YW; WEAR-Stroke Study Group. Improving patient outcomes in acute and subacute stroke using a wearable device-assisted rehabilitation system: a randomized controlled trial. J Int Med Res. 2024 Oct;52(10):3000605241281425. doi: 10.1177/03000605241281425.
PMID: 39387211DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 31, 2021
First Posted
August 9, 2021
Study Start
November 1, 2015
Primary Completion
November 1, 2017
Study Completion
April 1, 2018
Last Updated
May 17, 2022
Record last verified: 2022-05